Primary Sclerosing Cholangitis and Cholangiocarcinoma

Document Overview

Document Title

Primary Sclerosing Cholangitis and Cholangiocarcinoma

Authoring Society

American Association for the Study of Liver Diseases

Document Publication Date

Sep 9, 2022

Page Last Reviewed/Updated

May 5, 2026

Document Type

Guideline

Country of Publication

United States

Full Text Freely Available

Yes

Full Text Guideline

aasldpubs.onlinelibrary.wiley.com/doi/epdf/10.1002/hep.32771

Source Citation

Bowlus CL, Arrivé L, Bergquist A, Deneau M, Forman L, Ilyas SI, Lunsford KE, Martinez M, Sapisochin G, Shroff R, Tabibian JH, Assis DN. AASLD Practice Guidance on Primary Sclerosing Cholangitis and Cholangiocarcinoma. Hepatology. 2022 Sep 9. doi: 10.1002/hep.32771. Epub ahead of print. PMID: 36083140.

Supplemental Implementation Resources

• Quick-Reference Guide
• Patient Information

Document Scope, Criteria, and Use Cases

Scope

Assessment and Screening, Diagnosis, Management, Treatment

Diseases/Conditions (MeSH)

D018281 - Cholangiocarcinoma

D002761 - Cholangitis

D015209 - Cholangitis, Sclerosing

D018281 - Cholangiocarcinoma

D002761 - Cholangitis

D015209 - Cholangitis, Sclerosing

Keywords

Cholangiocarcinoma, cholangitis

Inclusion Criteria

Male, Female, Adult, Older Adult

Health Care Settings

Ambulatory, Operating and Recovery Room, Outpatient

Intended Users

Nurse, Nurse Practitioner, Physician, Physician Assistant

Recommendation Development Processes & Methodology

Number of Source Documents

1,015

Includes peer/external review process?

Yes

Includes public comment process?

No

Methodologist involvement?

Yes

Patient involvement?

No

Includes multi-disciplinary group?

Yes

Includes systematic review?

Yes

Grades quality of strength of evidence?

No

Grades quality of strength of recommendation?

No

Discloses funding source?

Yes

Discloses conflicts of interest?

Yes

Includes benefits/harms analysis with recommendations?

No